JP Morgan Chase’s Hologic HOLX Stock Holding History

JP Morgan Chase’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-74,200	Closed	-$5.55M	–	6940
2022 Q4	$5.55M	Buy	74,200 +72,600	+4,538%	+$5.17M	﹤0.01%	2738
2022 Q3	$103K	Buy	+1,600	New	+$111K	﹤0.01%	5269
2021 Q4	–	Sell	-4,600	Closed	-$340K	–	6779
2021 Q3	$340K	Buy	+4,600	New	+$345K	﹤0.01%	4940
2021 Q1	–	Sell	-30,500	Closed	-$2.22M	–	6181
2020 Q4	$2.22M	Buy	+30,500	New	+$2.15M	﹤0.01%	3402
2017 Q1	–	Sell	-135,000	Closed	-$5.42M	–	5126
2016 Q4	$5.42M	Hold	135,000	–	–	﹤0.01%	2388
2016 Q3	$5.24M	Hold	135,000	–	–	﹤0.01%	2215
2016 Q2	$4.67M	Buy	+135,000	New	+$4.67M	﹤0.01%	2340

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's HOLX Position: Q2 2026 in Review

JP Morgan Chase sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,301,493 shares — an estimated $249M sold.

JP Morgan Chase first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $271M in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

JP Morgan Chase reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
JP Morgan Chase sold 3,301,493 Hologic shares in Q2 2026, an estimated $249M.
JP Morgan Chase first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
JP Morgan Chase's Hologic position peaked at $271M in Q2 2023.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.